Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors – Dove Medical Press
|
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
Dove Medical Press Abstract: Nanomedicine application in cancer immunotherapy is currently one of the most challenging areas in cancer therapeutic intervention. Innovative solutions have been provided by nanotechnology to deliver cytotoxic agents to the cancer cells … |
